Comparison of marrow vs blood-derived stem cells for autografting in previously untreated multiple myeloma

British Journal of Cancer

Volumn 75, Issue 11, 1997, Pages 1684-1689

  Raje, N ^a   Powles, R ^a   Horton, C ^a   Millar, B ^a   Shepherd, V ^a   Middleton, G ^a   Kulkarni, S ^a   Eisen, T ^a   Mehta, J ^a   Singhal, S ^a   Treleaven, J ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Blood; Bone marrow; Myeloma; Stem cells

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; METHYLPREDNISOLONE; VINCRISTINE;

ADULT; AGED; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER REGRESSION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

EID: 8244227331     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.286     Document Type: Article

References (29)

1. Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet G, Rossi JF, Casassus P, Thyss A, Maisonneuve H, Facon T, Ifrah N, Payen C and Bataille R (1945) High dose therapy in multiple myeloma: final analysis of a prospective randomized study of the "Intergroupe Francais Du Myelome". Blood 86: 124a
2. Barlogie B, Hall R, Zander A, Dicke K and Alexanian R (1986) High-dose melphalan with autologous bone marrow transplantation for multiple myeloma. Blood 67: 1298-1301
3. Barlogie B, Anderson K, Berenson J, Crowley J, Cunningham D, Gertz M, Henon P, Horowitz M, Jagannath S, Powles R, Reece D, Reiffers J, Salmon S, Tricot G and Vesole D (1995) Transplants for multiple myeloma. Bone Marrow Transplant 15: s234-239
4. Belch AR, Szczepek A, Bergsagel PL and Pilarski LM (1995) Circulating CD34+ cells from peripheral blood in multiple myeloma include B cells with patient specific IGH CDR3 sequences and CD34mRNA as well as DNA hyperdiploidy and N-ras mutation. Blood 86: 276a
5. Bensinger WI, Longin K, Appelbaum F, Rowley S, Weaver C, Lillehy K, Gooley T, Lynch M, Higano T, Klarnet J, Chauncey T, Storb R and Buckner CD (1994) Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 87: 825-831
6. Corradini P, Voena C, Astolfi M, Ladetto M, Tarella C, Boccadoro M and Pileri A (1995) High-dose sequential chemoradiotherapy in multiple myeloma: residual tumour cells are detectable in bone marrow and peripheral blood stem cell harvests and after autografting. Blood 85: 1596-1602
7. Cunningham D, Powles R, Malpas J, Milan S, Meldrum M, Voner C, Montes A, Hickish T, Nicolson M, Johnson P, Mansi J, Treleaven J, Raymond J and Gore ME (1993) A randomised trial of maintenance therapy with Intron-A following high dose melphalan and ABMT in myeloma. ASCO Abstracts 12: 364
8. Cunningham D, Paz-Ares L, Milan S, Powles R, Nicolson M, Hickish T, Selby P, Treleaven J, Viner C, Malpas J, Slevin M, Findlay M, Raymond J and Gore ME (1994) High dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma. J Clin Oncol 12: 759-763
9. Demirer T, Buckner CD, Gooley T, Appelbaum FR, Rowley S, Chauncey T, Lilleby K, Storb R and Bensinger WI (1996) Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma. Bone Marrow Transplant 17: 937-941
10. Dimopoulos MA, Alexanian R, Przepiorka D, Hester J, Andersson B, Giralt S, Mehra R, Besien K, Delasalle K, Reading C, Deisseroth A and Champlin R (1993) Thiotepa. Busulfan and Cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high risk myeloma. Blood 82: 2324-2328
11. Dunbar CE, Cottler-Fox M, O'Shaoghnessy JA, et al (1995) Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long term engraftment alter autologous transplantation. Blood 3048-3057
12. Fermand JP, Chevret S, Ravaud P, Divine M, Leblond V, Dreyfus F, Mariette X and Brouet J (1993) High-dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma: results of a phase II trial involving 63 patients. Blood 82: 2005-2009
13. Gazitt Y, Reading C, Hoffman R, Wickrema A, Vesole D, Jagannath S, Condino J, Lee B, Barlogie B and Tricot G (1995) Purified CD34+ Lin- Thy+ stem cells do not contain clonal myeloma cells. Blood 86: 381-389
14. Gore ME, Selby PJ, Viner C, Clark PI, Meldrum M, Millar B, Bell J, Maitland JA, Milan S, Judson IR, Zuiable A, Tillyer C, Slevin M, Malpas JS and McElwain TJ (1989) Intensive treatment for multiple myeloma and criteria for complete remission. Lancet 11: 879-882
15. Harousseau JL, Attal M, Divine M, Marit G, Leblond V, Stoppa A, Bourhis J, Cailot D, Boassan M, Abgrall J, Facon T, Linassier C, Cahn Y, Lamy T, Troussard X, Gratecos N, Pignon B, Auzanneau G and Bataille R (1995a) Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French Registry on autologous transplantation in multiple myeloma. Blood 85: 3077-3085
16. Harousseau JL, Attal M, Divine M, Milpied N, Marit G, Leblond V, Stoppa A, Bourhis J, Caillot D, Boasson M, Agrall J, Facon T, Colombat P, Cahn J, Lamy T, Troussard X, Gratecos N, Pignon B and Auzanneau G (1995b) Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myeloma. Bone Marrow Transplant 15: 963-969
17. Kaplan EL and Meier P (1958) Non-parametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481
18. Kruskal WH and Wallis WA (1952) Use of ranks in one-criterion variance analysis. J Am Suit Assoc 47: 583-621
19. Mariette X, Fermand JP and Brouet JC (1994) Myeloma cell contamination of peripheral blood stem cell grafts in patients with multiple myeloma treated by high-dose therapy. Bone Marrow Transplant 14: 47-50
20. McElwain TJ and Powles RL (1983) High dose intravenous melphalan for plasma cell leukemia and myeloma. Lancet 2: 822-824
21. Peto R and Peto J (1972) Asymptomatically efficient invariant procedures. J R Stat Soc A 135: 185-206
22. Powles RL, Raje NS, Cunningham D, Malpas J, Milan S, Horton C, J Mehta, S Singhal, C Viner and J Treleaven (1995) Maintenance therapy for remission in myeloma with Intron A following either an autologous bone marrow transplantation or peripheral stem cell rescue. Stem Cells 13: 114-117
23. Powles R, Raje N, Horton C, Mehta J, Singhal S, Hickish T, Viner C, Milan S, Treleaven J and Cunningham D (1996) Comparison of interferon tolerance after autologous bone marrow or peripheral blood stem cell transplants for myeloma patients who have responded to induction therapy. Leukaemia and Lymphoma 21: 421-427
24. Raje NS, Powles RL, Horton CAP, et al (1995) Peripheral blood stem cell transplantation in multiple myeloma. Br J Haematol 89 (s1): 84
25. Rubia J, Bonanad S, Palau J, Sanz G and Sanz M (1994) Rapid progression of multiple myeloma following G-CSF mobilization. Bone Marrow Transplant 14: 475-476
26. Schiller G, Vescio R, Freytus C, Spitzer G, Sahebi F, Lee M, Wu C, Cao J, Lee J, Hong C, Lichtenstein A, Lill M, Hall J, Berenson R and Berenson J (1995) Transplantation of CD 34+ peripheral blood progenitor cells after high dose chemotherapy for patients with advanced multiple myeloma. Blood 86: 390-397
27. Selby PJ, McElwain TJ, Nandi AC, Perren TJ, Powles RL, Tillyer CR, Osborne RJ, Slevin ML, and Malpas JS (1987) Multiple myeloma treated with high dose intravenous melphalan. Br J Haematol 66: 52-55
28. Singhal S, Powles R, Milan S, Raje N, Viner C, Treleaven J, Raymond J, Cunningham D and Mehta J (1995) Kinetics of paraprotein clearance after autografting for multiple myeloma. Bone Marrow Transplant 16: 537-540
29. Tricot G, Jaganath S, Vesole D, Nelson J, Tindle S, Miller L, Cheson B, Crowley J and Barlogie B (1995) Peripheral blood stem cell transplantation for multiple myeloma: identification of favourable variables for rapid engrafiment in 225 patients. Blood 85: 588-596